Skip to content

Cardiac Elastography Measurement : an Intraoperative Cardiac Surgery Study

Measurement of Cardiac Elastography: an Intraoperative Cardiac Surgery Study. Cardiac Elastography in Vivo

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02051920
Acronym
REA-FO
Enrollment
30
Registered
2014-01-31
Start date
2013-11-30
Completion date
Unknown
Last updated
2015-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diastolic Dysfunction and Cardiac Stiffness

Keywords

Elastography

Brief summary

Since 20 years, the techniques of direct measurement of cardiac stiffness in the diagnosis of myocardial diseases do not exist. We propose a human study evaluating the direct measurement of cardiac ultrasound stiffness by elastography. This study will include 30 patients with cardiac disease whose rigidity varies with underlying disease. The purpose of this study is to evaluate the stiffness during open heart surgery.

Interventions

None listed

Sponsors

University Hospital, Rouen
CollaboratorOTHER
University Hospital, Caen
Lead SponsorOTHER

Study design

Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Written consent * Patients older than 18 years * Every patient scheduled for cardiac surgery * Cardiac catheterization within 6 months before surgery, * Women of childbearing age in effective contraception (a urine pregnancy test will be performed) * Patient affiliated or covered by a plan of health insurance. * Francophone

Exclusion criteria

* Pregnant or lactating woman, * Functional walking disability, * Patient placed under judicial protection: guardianship, * Patient participating in another trial and / or participated in another trial within two months, * Patient under guardianship or trusteeship, * Women who are not effective contraception, * Patient with no liberty by administrative or judicial decision

Design outcomes

Primary

MeasureTime frameDescription
Young's Modulus measurement according to the equation E = Young 3ρCs ²During herat surgery (Day 0)Ultrasound acquisition will be completed in epicardial vue using a linear probe SuperLinear 15-4 ™ connected to an ultrasound (AixplorerTM ® from Supersonic Imagine). The acquisitions will be completed in mode B + Elastrography Shear Wave ™ (SWE). A sterile gel is deposited in the bottom of the pouch of sterile protection of the probe. Many measurements will be done on accessible left and right ventricle areas. Measurement of Young's modulus: automated by the onboard model according to the equation E = Young 3ρCs ², where E is the Young's elastic modulus software, ρ is the tissue density and Cs the velocity of shear wave

Secondary

MeasureTime frameDescription
diastolic function parametersDay 0Correlation between young's modulus and diastolic function parameters is assess after surgery by post processing

Countries

France

Contacts

Primary ContactEric Saloux, MD
saloux-e@chu-caen.fr+330231064901
Backup ContactFabrice Bauer, MD,PhD
fabrice.bauer@chu-rouen.fr

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026